Literature DB >> 30165447

Dopamine regulates cytokine secretion during innate and adaptive immune responses.

Masaaki Kawano1, Rie Takagi1, Kikue Saika1, Masanori Matsui2, Sho Matsushita1,3.   

Abstract

Dopamine (DA) is synthesized by various immune cells. DA receptors (DARs), which comprise five isoforms, are expressed on the surface of these cells. Therefore, it is likely that DA plays a role in regulating innate and adaptive responses. However, the underlying molecular mechanism(s) is largely unknown. Here, we found that, during innate immune responses, DA suppressed secretion of IFN-γ, TNF-α and IL-1β, but promoted secretion of IL-10 and CXCL1 by lipopolysaccharide (LPS)-stimulated mouse splenocytes, suggesting that DA regulates cytokine secretion. Immune subset studies indicated that DA suppressed secretion of IFN-γ, TNF-α and IL-1β by NK cells, as well as secretion of TNF-α by neutrophils and monocytes; however, DA up-regulated IL-10 secretion by neutrophils, monocytes, B cells, macrophages (Mφs) and dendritic cells within the splenocyte population. In addition, DA up-regulated secretion of CXCL1 by LPS-stimulated NK cells and Mφs. Meanwhile, treatment with DAR agonists or antagonists suppressed secretion of inflammatory cytokines from LPS-stimulated splenocytes. Pre-treatment of LPS-stimulated splenocytes with the PI3K inhibitor wortmannin reversed DA-mediated suppression of IFN-γ secretion, indicating that DA regulates IFN-γ secretion via the inositol 1,4,5-trisphosphate signaling pathway in these cells. Administration of DA and LPS to mice immunized with chicken ovalbumin (OVA) increased secretion of IL-5 by mouse lung lymphocytes, suggesting that DA promotes OVA-specific Th2-mediated immune responses by these cells. Taken together, these findings indicate that DA regulates cytokine secretion during innate and adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30165447     DOI: 10.1093/intimm/dxy057

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  14 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 2.  Can't or Won't? Immunometabolic Constraints on Dopaminergic Drive.

Authors:  Michael T Treadway; Jessica A Cooper; Andrew H Miller
Journal:  Trends Cogn Sci       Date:  2019-04-02       Impact factor: 20.229

Review 3.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

4.  Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease.

Authors:  An-Qi Dong; Ya-Ping Yang; Shu-Min Jiang; Xiao-Yu Yao; Di Qi; Cheng-Jie Mao; Xiao-Yu Cheng; Fen Wang; Li-Fang Hu; Chun-Feng Liu
Journal:  Acta Pharmacol Sin       Date:  2022-07-27       Impact factor: 7.169

5.  Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons.

Authors:  Fiona Limanaqi; Silvia Zecchini; Borana Dino; Sergio Strizzi; Gioia Cappelletti; Olga Utyro; Claudia Vanetti; Micaela Garziano; Irma Saulle; Mario Clerici; Mara Biasin
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

6.  Oligoantigenic Diet Improves Children's ADHD Rating Scale Scores Reliably in Added Video-Rating.

Authors:  Anna Dölp; Katja Schneider-Momm; Philip Heiser; Christina Clement; Reinhold Rauh; Hans-Willi Clement; Eberhard Schulz; Christian Fleischhaker
Journal:  Front Psychiatry       Date:  2020-08-20       Impact factor: 4.157

Review 7.  Immunosuppressive Mechanisms of Regulatory B Cells.

Authors:  Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

8.  The peripheral dopamine 2 receptor antagonist domperidone attenuates ethanol enhancement of dopamine levels in the nucleus accumbens.

Authors:  James Daniel Obray; Eun Young Jang; Anneke M Klomp; Christina A Small; Aaron P Richardson; Joshua J LeBaron; Jin Gyeom Lee; Jordan T Yorgason; Chae Ha Yang; Scott C Steffensen
Journal:  Alcohol Clin Exp Res       Date:  2022-02-01       Impact factor: 3.455

9.  Early Adolescence Prefrontal Cortex Alterations in Female Rats Lacking Dopamine Transporter.

Authors:  Placido Illiano; Damiana Leo; Raul R Gainetdinov; Marta Pardo
Journal:  Biomedicines       Date:  2021-02-05

10.  Dopaminergic agonist pramipexole improves memory and increases IL-10 production in LPS-challenged rats.

Authors:  Anita Mihaylova; Nina Doncheva; Hristina Zlatanova; Delian Delev; Mariya Ivanovska; Yvetta Koeva; Marianna Murdjeva; Ilia Kostadinov
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.